NCT05108311: GIRDTREAT

Effectiveness of a Novel Protocol for Glenohumeral Internal Rotation Deficit in General Population With Shoulder Pain

Completed NA Last updated 14 July 2023

What this trial tests

NA trial testing Manual therapy and therapeutic exercise in Shoulder Pain in 35 participants. Completed in 30 January 2022.

Timeline

22 October 2021

Primary endpoint
31 December 2021

30 January 2022

Quick facts

Lead sponsor	CEU San Pablo University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	35
Start date	22 October 2021
Primary completion	31 December 2021
Estimated completion	30 January 2022
Sites	1 location across Spain

Drugs / interventions tested

• Manual therapy and therapeutic exercise

Conditions studied

• Shoulder Pain — all drugs for Shoulder Pain →
• Glenohumeral Internal Rotation Deficit — all drugs for Glenohumeral Internal Rotation Deficit →

Sponsor

CEU San Pablo University

Who can join

18 and older, any sex, with Shoulder Pain or Glenohumeral Internal Rotation Deficit. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Shoulder pain is one of the most common joint problems and disabling complaint in general population., but there is a lack of evidence about the relation between shoulder pain and glenohumeral internal rotation deficit (GIRD) in general population.

This study aimed to determine if the novel proposal for treatment of GIRD could be effectiveness and gain further evidence in the Range of Motion an Pain.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

1. Treatment of glenohumeral internal rotation deficit in the general population with shoulder pain: An open single-arm clinical trial.
   Jácome-López R, Tejada-Gallego J, Silberberg JM, García-Sanz F, et al · · 2023 · PMID 37747030 · DOI 10.1097/md.0000000000035263